Dechert Advises Protera on its US$5.6 Million Series A Financing Round
June 12, 2020
Dechert advised Protera, an AI-driven start-up designing and developing new proteins for the food, agriculture, environment and health industries, in connection with its US$5.6 million Series A financing led by Sofinnova Partners, a leading European life sciences venture capital firm. Existing shareholder SOSV, a U.S.-based tech venture capital firm, also participated.
The financing is intended to support the commercialization of Protera’s protein ingredient portfolio. The company is about to begin pilot trials with multinational food companies to deploy a unique, clean-label protein that extends shelf-life and replaces chemically-derived ingredients.
Dechert advised Protera on the following:
- Corporate aspects: Anne-Charlotte Rivière, partner, with Aude Steinberg, associate;
- Intellectual property aspects: Marie Fillon, national partner.
About Dechert
Dechert is a leading global law firm with 26 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.
Dechert is a leading global law firm with 26 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.